These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 16153896)
1. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Litman R; Peng M; Jin Z; Zhang F; Zhang J; Powell S; Andreassen PR; Cantor SB Cancer Cell; 2005 Sep; 8(3):255-65. PubMed ID: 16153896 [TBL] [Abstract][Full Text] [Related]
2. BRCA1-mediated repression of mutagenic end-joining of DNA double-strand breaks requires complex formation with BACH1. Dohrn L; Salles D; Siehler SY; Kaufmann J; Wiesmüller L Biochem J; 2012 Feb; 441(3):919-26. PubMed ID: 22032289 [TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852 [TBL] [Abstract][Full Text] [Related]
4. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424 [TBL] [Abstract][Full Text] [Related]
5. Redox regulation of the transcriptional repressor Bach1. Ishikawa M; Numazawa S; Yoshida T Free Radic Biol Med; 2005 May; 38(10):1344-52. PubMed ID: 15855052 [TBL] [Abstract][Full Text] [Related]
6. Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy. Eelen G; Vanden Bempt I; Verlinden L; Drijkoningen M; Smeets A; Neven P; Christiaens MR; Marchal K; Bouillon R; Verstuyf A Oncogene; 2008 Jul; 27(30):4233-41. PubMed ID: 18345034 [TBL] [Abstract][Full Text] [Related]
7. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2. Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162 [TBL] [Abstract][Full Text] [Related]
8. Assessing the link between BACH1 and BRCA1 in the FA pathway. Cantor SB; Andreassen PR Cell Cycle; 2006 Jan; 5(2):164-7. PubMed ID: 16357529 [TBL] [Abstract][Full Text] [Related]
9. FancJ (Brip1) loss-of-function allele results in spermatogonial cell depletion during embryogenesis and altered processing of crossover sites during meiotic prophase I in mice. Sun X; Brieño-Enríquez MA; Cornelius A; Modzelewski AJ; Maley TT; Campbell-Peterson KM; Holloway JK; Cohen PE Chromosoma; 2016 Jun; 125(2):237-52. PubMed ID: 26490168 [TBL] [Abstract][Full Text] [Related]
10. FANCJ: solving problems in DNA replication. Hiom K DNA Repair (Amst); 2010 Mar; 9(3):250-6. PubMed ID: 20122882 [TBL] [Abstract][Full Text] [Related]
11. FANCJ helicase operates in the Fanconi Anemia DNA repair pathway and the response to replicational stress. Wu Y; Brosh RM Curr Mol Med; 2009 May; 9(4):470-82. PubMed ID: 19519404 [TBL] [Abstract][Full Text] [Related]
12. The FANCJ/MutLalpha interaction is required for correction of the cross-link response in FA-J cells. Peng M; Litman R; Xie J; Sharma S; Brosh RM; Cantor SB EMBO J; 2007 Jul; 26(13):3238-49. PubMed ID: 17581638 [TBL] [Abstract][Full Text] [Related]
13. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer. Clapperton JA; Manke IA; Lowery DM; Ho T; Haire LF; Yaffe MB; Smerdon SJ Nat Struct Mol Biol; 2004 Jun; 11(6):512-8. PubMed ID: 15133502 [TBL] [Abstract][Full Text] [Related]
14. Abnormal rearrangements associated with V(D)J recombination in Fanconi anemia. Smith J; Andrau JC; Kallenbach S; Laquerbe A; Doyen N; Papadopoulo D J Mol Biol; 1998 Sep; 281(5):815-25. PubMed ID: 9719637 [TBL] [Abstract][Full Text] [Related]
15. A rapid method for retrovirus-mediated identification of complementation groups in Fanconi anemia patients. Chandra S; Levran O; Jurickova I; Maas C; Kapur R; Schindler D; Henry R; Milton K; Batish SD; Cancelas JA; Hanenberg H; Auerbach AD; Williams DA Mol Ther; 2005 Nov; 12(5):976-84. PubMed ID: 16084127 [TBL] [Abstract][Full Text] [Related]
16. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Levitus M; Waisfisz Q; Godthelp BC; de Vries Y; Hussain S; Wiegant WW; Elghalbzouri-Maghrani E; Steltenpool J; Rooimans MA; Pals G; Arwert F; Mathew CG; Zdzienicka MZ; Hiom K; De Winter JP; Joenje H Nat Genet; 2005 Sep; 37(9):934-5. PubMed ID: 16116423 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment. Martinez A; Hinz JM; Gómez L; Molina B; Acuña H; Jones IM; Frias S; Coleman MA Mutat Res; 2008 Oct; 656(1-2):1-7. PubMed ID: 18647660 [TBL] [Abstract][Full Text] [Related]
19. Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer. Lewis AG; Flanagan J; Marsh A; Pupo GM; Mann G; Spurdle AB; Lindeman GJ; Visvader JE; Brown MA; Chenevix-Trench G; Breast Cancer Res; 2005; 7(6):R1005-16. PubMed ID: 16280053 [TBL] [Abstract][Full Text] [Related]
20. Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1. Cantor SB; Guillemette S Future Oncol; 2011 Feb; 7(2):253-61. PubMed ID: 21345144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]